menu
    • menu

    Company profile for Gamida Cell

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Gamida Cell, we are striving to enable patients with blood cancers and serious blood disorders to reach cures through advanced cell therapy. We work with a sense of urgency and deeply held responsibility to address the clear need for new treatment options. And we believe that cell therapies should be available to patients who can benefit from them. We have assembled a proven team with deep expertise in cell therapy and drug...
    At Gamida Cell, we are striving to enable patients with blood cancers and serious blood disorders to reach cures through advanced cell therapy. We work with a sense of urgency and deeply held responsibility to address the clear need for new treatment options. And we believe that cell therapies should be available to patients who can benefit from them. We have assembled a proven team with deep expertise in cell therapy and drug development that is committed to bringing life-changing treatments to patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Gamida CellIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    5 Nahum Hafzadi Street, Givat Shaul Jerusalem, Israel 95484
    Telephone
    Telephone
    617-892-9084
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gamida-cell.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gamida-cell-ltd-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/GamidaCellTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioAsia

    Not Confirmed

    envelop Contact Supplier

    BioAsia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ayrmid Appoints ACA Pharma As Exclusive Distributor
    Ayrmid Appoints ACA Pharma As Exclusive Distributor

    09 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-09/ayrmid-appoints-aca-pharma-as-exclusive-distributor-for-omisirge-r-across-greater-china-and-southea

    PHARMIWEB
    09 Feb 2026
    Share Share
    Ayrmid and Ariti Sign Omisirge Deal in Greece and Cyprus
    Ayrmid and Ariti Sign Omisirge Deal in Greece and Cyprus

    05 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-05/ayrmid-and-ariti-sign-distribution-agreement-for-omisirge-r-in-greece-and-cyprus

    PHARMIWEB
    05 Feb 2026
    Share Share
    Omisirge Shows Further Efficacy In Severe Aplastic Anemia At ASH
    Omisirge Shows Further Efficacy In Severe Aplastic Anemia At ASH

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/additional-positive-results-for-omisirge-r-in-treating-severe-aplastic-anemia-presented-at-ash

    PHARMIWEB
    08 Dec 2025
    Share Share
    Ayrmid Reports Promising New Real-World Data on Motixafortide
    Ayrmid Reports Promising New Real-World Data on Motixafortide

    06 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-06/ayrmid-reports-promising-new-real-world-data-on-motixafortide-for-stem-cell-mobilization-in-sickle-c

    PHARMIWEB
    06 Dec 2025
    Share Share
    FDA Approves Omisirge(R) For Severe Aplastic Anemia
    FDA Approves Omisirge(R) For Severe Aplastic Anemia

    05 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-05/fda-approves-omisirge-r-as-first-approved-cell-therapy-to-treat-severe-aplastic-anemia

    PHARMIWEB
    05 Dec 2025
    Share Share
    Gamida Cell Reports Positive Results for Omidubicel in SAA
    Gamida Cell Reports Positive Results for Omidubicel in SAA

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251027168884/en/Gamida-Cell-Presents-Positive-Initial-Results-on-Treating-Severe-Aplastic-Anemia-SAA-with-Omidubicel

    BUSINESSWIRE
    28 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search